Skip to content
BidBenchmark

Contract award

MILECELL BIOTECHNOLOGY INC.

PRIMARY HUMAN TROPHOBLAST CELLS
PIID
75F40126P00211
Award key
CONT_AWD_75F40126P00211_7524_-NONE-_-NONE-
Recipient UEI
KLF8HJ4A4UD3
Source as of
Current award value
$24,7503
Obligated to date
$24,7502
Potential with options
$24,7503
Awarding agency
Department of Health and Human ServicesFood and Drug Administration
Place of performance
San Diego, California
Set-aside
No set-aside used
Pricing
Firm Fixed Price
Competition
Competed under SAP1 offers received
Period of performance
Sep 9, 2026Dec 31, 2026Through Dec 31, 2026 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
0Sep 9, 2026Initial award$24,750.00$24,750.00

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f1cc6d76c5fe
contractor_idUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f1cc6d76c5fe
current_award_valueUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f1cc6d76c5fe
naics_codeUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f1cc6d76c5fe
potential_award_valueUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f1cc6d76c5fe
psc_codeUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f1cc6d76c5fe
total_obligatedUSAspending.govSep 11, 2026usaspending_contract_csv@2026.08.2f1cc6d76c5fe

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 1 transaction records parsed from USAspending.gov, retrieved Sep 11, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
75F40126P00211 — MILECELL BIOTECHNOLOGY INC. · BidBenchmark